Our vision

"To discover the biology underlying human health, improving the treatment, diagnosis and prevention of human disease and generate economic opportunities for the UK."

The Francis Crick Institute is a new and distinctive medical research institute. The institute is located in London, but our vision is UK-wide and relevant world-wide.

Our work will help to understand why disease develops and to find new ways to diagnose, prevent and treat a range of illnesses − such as cancer, heart disease, stroke, infections and neurodegenerative diseases. We will bring together outstanding scientists from all disciplines, carrying out research that will help improve the health and quality of people's lives, and keeping the UK at the forefront of medical innovation.

Artery remodelling, regression and rearrangement

Remodelling of artery comprising vessel regression (red) and endothelial junction rearrangement (green)

We are: 

  • Bold

We support ground-breaking discovery science, pursue excellence on the international stage and are not afraid to do things differently.

  • Imaginative

We take a long-term view, encourage creative approaches and explore connections between disciplines.

  • Open

We are permeable to outside talent and ideas and committed to transparent science for the public good that meets the highest ethical, animal welfare and biosecurity standards.

  • Dynamic

We continually develop and refresh our science, are open to pursuing new opportunities and adaptable enough to change course quickly.

  • Collegial

We mentor and support our staff, forge scientific connections in the UK and internationally and work with our founders and the public to support the development of the UK science and innovation ecosystem.

  • To realise our vision, we will be bold, imaginative, open, dynamic and collegial.
  • Leading researchers from a range of scientific disciplines will collaborate to uncover fundamental biological mechanisms underlying human health and disease.
  • The Francis Crick Institute is led by Chief Executive, Sir Paul Nurse, a Nobel Prize-winning biologist and President of the Royal Society.